No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BNGO240517C7000
- 0.10
- 0.000.00%
15min DelayTrading Mar 27 15:36 ET
0.00High0.00Low
0.00Open0.10Pre Close0 Volume3 Open Interest7.00Strike Price0.00Turnover885.41%IV631.13%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type0.2207Delta0.2220Gamma9.71Leverage Ratio-0.0228Theta0.0000Rho2.14Eff Leverage0.0004Vega
Intraday
- 5D
- 1D
News
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript
BioNano Genomics (BNGO) Gets a Buy From Scotiabank
Q1 2024 Bionano Genomics Inc Earnings Call
Bionano Genomics Inc (BNGO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
Bionano Announces Series of Major Advancements to Its Suite of Computational Tools for Comprehensive Cancer Analysis
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced significant upgrades to its suite of computational tools for comprehensive cancer analysis. These ad
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
Comments
$Bionano Genomics(BNGO.US$ Scotiabank BUY rating $6.00 Target Price
$Bionano Genomics(BNGO.US$ Bionano Genomics Q1 2024 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $8.769M Beat $8.492M Estimate
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
$Bionano Genomics(BNGO.US$ $0.08 per shares now 🤣🤣🤣🤣 used to he $12 at lrak LMFAO
$Bionano Genomics(BNGO.US$ Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines Ogm and Artificial Intelligence
$Bionano Genomics(BNGO.US$ b i n go b i ngo b i ngo and bingo crashed to 1 cent !
Read more